Literature DB >> 1409368

Pharmacokinetics of oral 2',3'-dideoxyinosine in rats.

M G Wientjes1, J L Au.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1409368     DOI： 10.1023/a:1015872026094

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  6 in total

1.  Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.

Authors:  X Gao; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

2.  Lack of absorption of didanosine after rectal administration in human immunodeficiency virus-infected patients.

Authors:  U Wintergerst; B Rolinski; B Sölder; J R Bogner; E Wolf; H Jäger; A A Roscher; B H Belohradsky
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

3.  Absorption of 2',3'-dideoxyinosine from lower gastrointestinal tract in rats and kinetic evidence of different absorption rates in colon and rectum.

Authors:  S L Bramer; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

4.  Percutaneous absorption of 2',3'-dideoxyinosine in rats.

Authors:  E Mukherji; N J Millenbaugh; J L Au
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

5.  Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.

Authors:  B D Anderson; M E Morgan; D Singhal
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

6.  Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats.

Authors:  Mai Hashimoto; Kazuaki Taguchi; Takako Ishiguro; Satoru Kohgo; Shuhei Imoto; Keishi Yamasaki; Hiroaki Mitsuya; Masaki Otagiri
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.